- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 Vaccine: Between Myth and Truth
Authors
Keywords
-
Journal
Vaccines
Volume 10, Issue 3, Pages 349
Publisher
MDPI AG
Online
2022-02-24
DOI
10.3390/vaccines10030349
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
- (2022) Hung Fu Tseng et al. NATURE MEDICINE
- Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera
- (2022) Alexander Muik et al. SCIENCE
- The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0–3.3 Days Can Be Explained by Immune Evasion
- (2022) Frederic Grabowski et al. Viruses-Basel
- Fourth dose of COVID-19 vaccines in Israel
- (2022) Talha Khan Burki Lancet Respiratory Medicine
- Genomic perspectives on the emerging SARS-CoV-2 omicron variant
- (2022) Wentai Ma et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to December 2020
- (2021) Antonin Bal et al. Eurosurveillance
- Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design
- (2021) Xuhua Xia Viruses-Basel
- Nanomaterial Delivery Systems for mRNA Vaccines
- (2021) Michael D. Buschmann et al. Vaccines
- Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
- (2021) Piyada Supasa et al. CELL
- Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera
- (2021) Daming Zhou et al. CELL
- The conundrum of current anti-SARS-CoV-2 vaccines
- (2021) Maurizio Federico CYTOKINE & GROWTH FACTOR REVIEWS
- Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
- (2021) Ester C Sabino et al. LANCET
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
- (2021) Zijun Wang et al. NATURE
- Neutralizing Activity of BNT162b2-Elicited Serum
- (2021) Yang Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera
- (2021) Alexander Muik et al. SCIENCE
- Viral Vectors for COVID-19 Vaccine Development
- (2021) Kenneth Lundstrom Viruses-Basel
- SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
- (2021) Nikolaos C. Kyriakidis et al. npj Vaccines
- SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
- (2021) Emily Bettini et al. Vaccines
- Antibody evasion by the P.1 strain of SARS-CoV-2
- (2021) Wanwisa Dejnirattisai et al. CELL
- Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
- (2021) Tjede Funk et al. Eurosurveillance
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
- (2021) Eric J Haas et al. LANCET
- Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
- (2021) Katherine R W Emary et al. LANCET
- Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
- (2021) Sandile Cele et al. NATURE
- Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7
- (2021) Nicholas G. Davies et al. NATURE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Equitable and Feasible Distribution of SARS-CoV-2 Vaccines for All in Africa
- (2021) Abu Bakarr Rogers et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Coronavirus disease 2019 (COVID-19) is a healthcare dilemma for human immunodeficiency virus (HIV)–positive individuals in Pakistan
- (2021) Ali Raza et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis
- (2021) Didier Ducloux et al. KIDNEY INTERNATIONAL
- Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
- (2021) Emma C Wall et al. LANCET
- Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
- (2021) Galit Alter et al. NATURE
- BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
- (2021) Ugur Sahin et al. NATURE
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
- (2021) Nassim Kamar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
- (2021) Victoria G. Hall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
- (2021) Yinon M. Bar-On et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adenoviral Vector DNA- and SARS-CoV-2 mRNA-Based Covid-19 Vaccines: Possible Integration into the Human Genome - Are Adenoviral Genes Expressed in Vector-based Vaccines?
- (2021) Walter Doerfler VIRUS RESEARCH
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- (2021) Sandra Lopez-Leon et al. Scientific Reports
- Dynamics of SARS-CoV-2 mutations reveals regional-specificity and similar trends of N501 and high-frequency mutation N501Y in different levels of control measures
- (2021) Santiago Justo Arevalo et al. Scientific Reports
- Review: Vaccine Myth-Buster – Cleaning Up With Prejudices and Dangerous Misinformation
- (2021) Paul Löffler Frontiers in Immunology
- COVID-19 vaccines and decreased transmission of SARS-CoV-2
- (2021) A. Vitiello et al. INFLAMMOPHARMACOLOGY
- Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge
- (2021) R. Glenn King et al. Vaccines
- Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza
- (2021) Yalda Rahbar Saadat et al. Frontiers in Molecular Biosciences
- The third booster vaccination dose against COVID-19: indications for circulating SARS-CoV-2 variants
- (2021) Farid Rahimi et al. Future Virology
- Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
- (2021) Mohamad-Gabriel Alameh et al. IMMUNITY
- Effectiveness of a Third Dose of BNT162b2 mRNA Vaccine
- (2021) Yaki Saciuk et al. JOURNAL OF INFECTIOUS DISEASES
- Oral Vaccination Protects Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Syrian Hamster Challenge Model
- (2021) Susan Johnson et al. JOURNAL OF INFECTIOUS DISEASES
- Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum
- (2021) Wanwisa Dejnirattisai et al. LANCET
- Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
- (2021) Noam Barda et al. LANCET
- China’s COVID vaccines have been crucial — now immunity is waning
- (2021) Smriti Mallapaty NATURE
- Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa
- (2021) Shirley Collie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma Neutralization of the SARS-CoV-2 Omicron Variant
- (2021) Fabian Schmidt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
- (2021) Mahesh S. Dhar et al. SCIENCE
- Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo
- (2021) Matt D. T. Hitchings et al. Nature Communications
- Highly mutated SARS-CoV-2 Omicron variant sparks significant concern among global experts – What is known so far?
- (2021) Sujan Poudel et al. Travel Medicine and Infectious Disease
- Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) Variant Cluster — Nebraska, November–December 2021
- (2021) Lauren Jansen et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021
- (2021) MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Emerging coronaviruses: Genome structure, replication, and pathogenesis
- (2020) Yu Chen et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Rational Vaccine Design in the Time of COVID-19
- (2020) Dennis R. Burton et al. Cell Host & Microbe
- A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
- (2020) Dorottya Laczkó et al. IMMUNITY
- Developing a SARS-CoV-2 Vaccine at Warp Speed
- (2020) Kevin P. O’Callaghan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
- (2020) Eskild Petersen et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
- (2020) Kizzmekia S. Corbett et al. NATURE
- ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
- (2020) Neeltje van Doremalen et al. NATURE
- Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
- (2020) F. Javier Ibarrondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccines for COVID‐19
- (2020) J. S. Tregoning et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Characteristics of SARS-CoV-2 and COVID-19
- (2020) Ben Hu et al. NATURE REVIEWS MICROBIOLOGY
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospects for mucosal vaccine: shutting the door on SARS-CoV-2
- (2020) Rajat Mudgal et al. Human Vaccines & Immunotherapeutics
- Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
- (2020) Wen Shi Lee et al. Nature Microbiology
- Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
- (2020) Allison J. Greaney et al. Cell Host & Microbe
- Reinfection with SARS-CoV-2: Implications for Vaccines
- (2020) Jeffrey I Cohen et al. CLINICAL INFECTIOUS DISEASES
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
- (2020) Alicia T. Widge et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entry
- (2020) Georgia Ragia et al. PHARMACOGENOMICS
- Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19
- (2020) Kenneth Lundstrom Viruses-Basel
- SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
- (2020) Mei-Yue Wang et al. Frontiers in Cellular and Infection Microbiology
- COVID-19 vaccines: The status and perspectives in delivery points of view
- (2020) Jee Young Chung et al. ADVANCED DRUG DELIVERY REVIEWS
- Mucosal Vaccination via the Respiratory Tract
- (2019) Hellfritzsch et al. Pharmaceutics
- Immunology‐Guided Biomaterial's Design as Mucosal Cancer Vaccine
- (2019) Shiran Ferber et al. ADVANCED MATERIALS
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design
- (2017) Timothy Pepini et al. JOURNAL OF IMMUNOLOGY
- Viral vectors as vaccine platforms: from immunogenicity to impact
- (2016) Katie J Ewer et al. CURRENT OPINION IN IMMUNOLOGY
- Vaccine hesitancy
- (2013) Eve Dubé et al. Human Vaccines & Immunotherapeutics
- Developing mRNA-vaccine technologies
- (2012) Thomas Schlake et al. RNA Biology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started